Citations

Clear

91 citation(s) found for "Coon, Elizabeth".

Chorea Associated with Lamotrigine Use: A case report, retrospective chart review, and literature summary (P2-11.014)
Hanson, Sofia, Badihian, Negin , Smith, Kelsey R. , Coon, Elizabeth A.

Mayo Clinic

Neurology | April 28, 2023 | Volume: 100 | Issue: 17_supplement_2 | Pages: No page available

10.1212/wnl.0000000000201778 Get It

The Effects of Deep Brain Stimulation in Patients with Multiple System Atrophy
Jackson, Lauren , Klassen, Bryan T. , Hassan, Anhar , Low, Phillip A. , Badihian, Negin , Jackson, Lauren M, Singer, Wolfgang , Coon, Elizabeth A.

Mayo Clinic

Journal of Parkinson's Disease | November 22, 2022 | Volume: 12 | Issue: 8 | Pages: 2595-2600

10.3233/jpd-223504 | PMID 36442207 Get It

The course of patients with multiple system atrophy (MSA) who undergo deep brain stimulation (DBS) is unclear. In a retrospective review of 1,496 patients with MSA evaluated at our institutions from 1998–2021, 12 patients underwent DBS; 9 had a diagnosis of Parkinson’s disease at the time of surgery. Nine patients reported initial improvement in at least one symptom and 7 experienced overall worsening following DBS. All patients had at least one red flag sign or symptom suggesting atypical parkinsonism prior to surgery. Considering overall poor outcomes of DBS in MSA, we recommend careful consideration of red flags in patient selection.
Nocturnal Pulse Event Frequency Is Reduced in Multiple System Atrophy
McCarter, Stuart J. , Benarroch, Eduardo E. , Silber, Michael H. , Louis, Erik K. St. , St Louis, E K , McCarter, Stuart J , Coon, Elizabeth A.

Mayo Clinic

Annals of Neurology | October 17, 2022 | Volume: 93 | Issue: 1 | Pages: 205-212

10.1002/ana.26533 | PMID 36251404 Get It

Risk of sudden death in multiple system atrophy (MSA) is greatest during sleep with unknown mechanisms. We compared nocturnal pulse event frequency in 46 MSA patients and age‐/sex‐matched controls undergoing overnight pulse oximetry. Nocturnal oxyhemoglobin desaturation indices and pulse event indices (PEIs) were recorded, and relationships between pulse oximetry variables and survival were analyzed. MSA patients had lower PEI (3.1 ± 5.3 vs. 12.8 ± 10.8, p < 0.001) despite greater hypoxic burden and similar frequency of respiratory events. Nocturnal pulse events were not associated with severity of daytime autonomic failure. Two MSA patients had suspected sudden death, both with severely reduced PEI. MSA patients have fewer nocturnal pulse events compared with controls, despite similar respiratory event frequency, suggesting abnormal cardiac responses to sleep‐disordered breathing. Whether this contributes to sudden death in MSA requires further study. ANN NEUROL 2023;93:205–212
0626 Nocturnal Pulse Event Frequency in Multiple System Atrophy: An Exploratory Pilot Study
Benarroch, Eduardo E. , McCarter, Stuart J. , Coon, Elizabeth A. , Louis, Erik K. St.

Mayo Clinic

Sleep | May 31, 2022 | Volume: 45 | Issue: Supplement_1 | Pages: A275-A275

10.1093/sleep/zsac079.623 Get It

Abstract Introduction Risk of sudden death in multiple system atrophy (SuD-MSA) is greatest during sleep. Mechanisms underlying SuD-MSA may involve impaired brainstem arousal and cardiovascular responses to hypercapnia in MSA patients. We hypothesized that nocturnal arousal-related tachycardia events are reduced in MSA patients. We analyzed whether nocturnal pulse event frequency was altered in patients with MSA compared to patients with sleep disordered breathing without MSA utilizing portable overnight oximetry. Methods We retrospectively analyzed 46 probable MSA and 46 age-sex matched patients with sleep disordered breathing (SDB) without MSA, excluding patients receiving cardioactive medications. Nocturnal oxyhemoglobin desaturation indices (ODI) and pulse event indices (PEI) were automatically recorded for all patients using portable overnight oximetry. We calculated a PEI/ODI ratio to determine the relationship between probable breathing-related arousals and pulse rate change. Cardiovagal function was assessed by heart rate to deep breathing and Valsalva ratio in patients with MSA and Composite Autonomic Severity Score was assigned. Group comparisons were made with non-parametric tests. Multivariable regression explored relationships between oximetry variables and clinical characteristics. Results Average age at overnight oximetry was 62.9 ± 7.7 years. Total respiratory events between MSA patients compared with OSA controls were similar (95.0 ± 118.6 vs 73.5± 54.2, p=0.61). Total pulse events were lower in MSA than OSA controls without MSA (25.5±44.2 vs 111.6±120.2, p&lt;0.001), as were pulse events per hour (3.1 ± 5.3 vs. 12.8 ± 10.8, p &lt;0.001). The ratio of PEI/ODI was lower in MSA than OSA patients without MSA (p&lt;0.001). Twelve (26%) MSA patients had zero pulse rate events, while all OSA patients without MSA had at least 1 pulse rate event (p&lt;0.001). The number of pulse events was not associated with severity of cardiovagal dysfunction on daytime autonomic function testing. Conclusion Patients with MSA have fewer pulse rate events when compared with SDB patients without MSA, despite similar overall respiratory event frequency. The number of pulse events was not explained by severity of daytime autonomic dysfunction in those with MSA. Whether nocturnal pulse event response to sleep disordered breathing is a marker of disease severity or plays a role in SuD-MSA deserves further study. Support (If Any)
Women in the Mayo Clinic Department of Neurology in its early years
Smith, Kelsey M. , Coon, Elizabeth A. , Boes, Christopher J. , Coon, Elizabeth Anne , Smith, Kelsey M

Mayo Clinic

Baylor University Medical Center Proceedings | May 31, 2022 | Volume: 35 | Issue: 5 | Pages: 649-654

10.1080/08998280.2022.2078636 | PMID 35991742 Get It

Dr. Betty Clements
Coon, Elizabeth A. , Smith, Kelsey M., Boes, Christopher J. , Coon, Elizabeth Anne , Boes, Christoper J , Smith, Kelsey M.

Mayo Clinic

Neurology | March 15, 2022 | Volume: 98 | Issue: 20 | Pages: 841-846

10.1212/wnl.0000000000200322 | PMID 35292557 Get It

Standardized Autonomic Testing in Patients With Probable Radiation-Induced Afferent Baroreflex Failure
Lamotte, Guillaume , Coon, Elizabeth A., Suarez, Mariana D., Sandroni, Paola, Benarroch, Eduardo, Cutsforth‐Gregory, Jeremy K. , Mauermann, Michelle L., Berini, Sarah E., Shouman, Kamal, Sletten, David, Goodman, Brent P., Low, Phillip A., Mauermann, Michelle L. , Singer, Wolfgang , Mauermann, Michelle L , Lamotte, Guillaume , Coon, Elizabeth A., Suarez, Mariana D., Sandroni, Paola, Benarroch, Eduardo, Cutsforth-Gregory, Jeremy K , Berini, Sarah E., Shouman, Kamal, Sletten, David, Goodman, Brent P., Low, Phillip A.

Mayo Clinic

Hypertension | November 5, 2021 | Volume: 79 | Issue: 1 | Pages: 50-56

10.1161/hypertensionaha.121.17805 | PMID 34739766 Get It

Injury of the afferent limb of the baroreflex from neck radiation causes radiation-induced afferent baroreflex failure (R-ABF). Identification and management of R-ABF is challenging. We aimed to investigate the pattern of autonomic dysfunction on standardized autonomic testing in patients with probable R-ABF. We retrospectively analyzed all autonomic reflex screens performed at Mayo Clinic in Rochester, MN, between 2000 and 2020 in patients with probable R-ABF. Additional tests reviewed included ambulatory blood pressure monitoring, plasma norepinephrine, and thermoregulatory sweat test. We identified 90 patients with probable R-ABF. Median total composite autonomic severity score (range, 0–10) was 7 (interquartile range, 6–7). Cardiovascular adrenergic impairment was seen in 85 patients (94.4%), increased blood pressure recovery time after Valsalva maneuver in 71 patients (78.9%; median 17.4 seconds), and orthostatic hypotension in 68 patients (75.6%). Cardiovagal impairment was demonstrated by abnormal heart rate responses to deep breathing (79.5%), Valsalva ratio (87.2%), and vagal baroreflex sensitivity (57.9%). Plasma norepinephrine was elevated and rose appropriately upon standing (722–1207 pg/mL). Ambulatory blood pressure monitoring revealed hypertension, postural hypotension, hypertensive surges, tachycardia, and absence of nocturnal dipping. Blood pressure lability correlated with impaired vagal baroreflex function. Postganglionic sympathetic sudomotor function was normal in most cases; the most frequent thermoregulatory sweat test finding was focal neck anhidrosis (78.9%). Standardized autonomic testing in R-ABF demonstrates cardiovascular adrenergic impairment with orthostatic hypotension, blood pressure lability, and elevated plasma norepinephrine. Cardiovagal impairment is common, while sudomotor deficits are limited to direct radiation effects.
Loss of putative GABAergic neurons in the ventrolateral medulla in multiple system atrophy
Schmeichel, Ann M., Parisi, Joseph E., Singer, Wolfgang , Low, Phillip A. , Benarroch, Eduardo E. , Singer, Wolfgang , Coon, Elizabeth A.

Mayo Clinic

Sleep | March 23, 2021 | Volume: 44 | Issue: 9 | Pages: No page available

10.1093/sleep/zsab074 | PMID 33755181 Get It

Abstract Study Objectives Multiple system atrophy (MSA) is associated with disturbances in cardiovascular, sleep and respiratory control. The lateral paragigantocellular nucleus (LPGi) in the ventrolateral medulla (VLM) contains GABAergic neurons that participate in control of rapid eye movement (REM) sleep and cardiovagal responses. We sought to determine whether there was loss of putative GABAergic neurons in the LPGi and adjacent regions in MSA. Methods Sections of the medulla were processed for GAD65/67 immunoreactivity in eight subjects with clinical and neuropathological diagnosis of MSA and in six control subjects. These putative GABAergic LPGi neurons were mapped based on their relationship to adjacent monoaminergic VLM groups. Results There were markedly decreased numbers of GAD-immunoreactive neurons in the LPGi and adjacent VLM regions in MSA. Conclusions There is loss of GABAergic neurons in the VLM, including the LPGi in patients with MSA. Whereas these findings provide a possible mechanistic substrate, given the few cases included, further studies are necessary to determine whether they contribute to REM sleep-related cardiovagal and possibly respiratory dysregulation in MSA.
Autonomic Dysfunction in the Synucleinopathies
Coon, Elizabeth A.

Mayo Clinic

Seminars in Neurology | September 9, 2020 | Volume: 40 | Issue: 05 | Pages: 492-501

10.1055/s-0040-1713844 | PMID 32906169 Get It

AbstractAutonomic dysfunction is a characteristic feature in the synucleinopathies. Differences in cellular deposition and neuronal populations affected by α-synuclein aggregation influence the manifestations and severity of autonomic failure in the different synucleinopathy disorders. The Lewy body disorders (Parkinson's disease, dementia with Lewy bodies, and pure autonomic failure) have predominantly peripheral involvement, whereas multiple system atrophy chiefly manifests as central autonomic failure. Clinical and laboratory features may be useful in distinguishing the different synucleinopathies based on the pattern and severity of autonomic failure. Treatment recommendations are aimed at the underlying pathophysiology and utilize non-pharmacologic and pharmacologic approaches. This review will focus on pathophysiology, clinical manifestations, and management recommendations for autonomic failure including neurogenic orthostatic hypotension, thermoregulatory dysfunction, genitourinary dysfunction, and gastrointestinal dysfunction in the synucleinopathies.